AI could revolutionize cancer diagnosis in new study
NCT ID NCT07269236
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new artificial intelligence (AI) system that combines information from tissue samples, scans, and medical records to help doctors better diagnose and treat cancer. Researchers will enroll 2000 adults with various cancers to see how well the AI can classify tumors, predict treatment responses, and support personalized care. The goal is to speed up the use of AI in everyday cancer care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, 510515, China
-
Zhongshan City People's Hospital
Zhongshan, Guangdong, 513000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.